https://tonic.inserm.fr/wp-content/uploads/2019/09/equipe-homme-defaut-150x150.jpg
 

Vincent LUBRANO

PH

    Abstracts rédigés ou co-rédigés

  • > New neuroimaging technologies in SPM: BIDS, docker, boutique, and quality control.

    Duval, T., Lubrano, V

    27th Annual Meeting of ISMRM 2019 - 12-16 Mai 2019 à Montréal. CANADA.
  • > Combined diffusion and perfusion MRI in Glioblastoma predicts glial stem cells proliferation and aggressiveness.

    Duval, T., Lotterie, J-A., Lemarie, A., Delmas, C., Toulas, C., Moyal, E., Lubrano, V.

    27th Annual Meeting of ISMRM 2019 - 12-16 Mai 2019 à Montréal. CANADA. Le Cancer Study Group award a été attribué pour ce poster
  • > Novalis Stereotactic Radiosurgery for Vestibular Schwannomas: the Toulouse Stereotactic Radiosurgery Unit experience

    V.F. Lubrano, V. Delabar, J.-A. Lotterie, P. Duthil, S. Monfraix, B. Debono, B. De Germay, F. Thouveny, J.-C. Sol, I. Latorzeff, J.F. Sabatier.

    EANS 2018 Annual Meeting Controversies and Solutions in Neurosurgery, October 21-25​ 2018, Bruxelles.
  • > Subventricular zones: new key targets for glioblastoma treatment

    J. Khalifa, F. Tensaouti, A. Lusque, B. Plas, J.A. Lotterie, E. Uro-Coste, V. Lubrano, E. Cohen-Jonathan Moyal

    ESTRO - European SocieTy of RADIOTHERAPY&ONCOLOGY - TURIN
  • > Zones subventriculaires : de nouvelles cibles pour le traitement des glioblastomes

    J.Khalifa, F.Tensaouti, A.Lusque, B.Plas, J.A.Lotterie, A.Benouaich-Amiel, E.Uro-coste, V.Lubrano, É.Cohen-Jonathan Moyal

    SFRO- Sociéte Française de Radiothérapie Oncologique - PARIS
  • > Outcomes after Surgery and Adjuvant Therapy for Glioblastoma : Results of a Single Institution Retrospective Study

    V Lubrano, B Plas, J. Khalifa, F Tensaouti, JC Sol, E. Cohen-Jonathan Moyal

    Société Française de Neurochirurgie - MONTPELLIER

    Publications rédigées ou co-rédigées

  • > 45- Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging.

    Freyschlag CF, Krieg SM, Kerschbaumer J, Pinggera D, Forster MT, Cordier D, Rossi M, Miceli G, Roux A, Reyes A, Sarubbo S, Smits A, Sierpowska J, Robe PA, Rutten GJ, Santarius T, Matys T, Zanello M, Almairac F, Mondot L, Jakola AS, Zetterling M, Rofes A, von Campe G, Guillevin R, Bagatto D, Lubrano V, Rapp M, Goodden J, De Witt Hamer PC, Pallud J, Bello L, Thomé C, Duffau H, Mandonnet E.

    J Neurooncol. 2018 Sep;139(3):699-711. doi: 10.1007/s11060-018-2916-3.
  • > 35- Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging.

    Laprie A, Ken S, Filleron T, Lubrano V, Vieillevigne L, Tensaouti F, Catalaa I, Boetto S, Khalifa J, Attal J, Peyraga G, Gomez-Roca C, Uro-Coste E, Noel G, Truc G, Sunyach MP, Magné N, Charissoux M, Supiot S, Bernier V, Mounier M, Poublanc M, Fabre A, Delord JP, Cohen-Jonathan Moyal E.

    BMC Cancer. 2019 Feb 21;19(1):167. doi: 10.1186/s12885-019-5317-x.
  • > 10- Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging.

    Laprie A, Ken S, Filleron T, Lubrano V, Vieillevigne L, Tensaouti F, Catalaa I, Boetto S, Khalifa J, Attal J, Peyraga G, Gomez-Roca C, Uro-Coste E, Noel G, Truc G, Sunyach MP, Magné N, Charissoux M, Supiot S, Bernier V, Mounier M, Poublanc M, Fabre A, Delord JP, Cohen-Jonathan Moyal E.

    BMC Cancer. 2019 Feb 21;19(1):167. doi: 10.1186/s12885-019-5317-x.
  • > 46- Inhibiting Integrin β8 to Differentiate and Radiosensitize Glioblastoma-initiating Cells.

    Malric L, Monferran S, Delmas C, Arnauduc F, Dahan P, Boyrie S, Deshors P, Lubrano VF, Ferreira Da Mota D, Gilhodes J, Filleron T, Siegfried A, Evrard SM, Kowalski-Chauvel A, Cohen-Jonathan Moyal E, Toulas C, Lemarié A.

    Mol Cancer Res. 2018 Sep 28. pii: molcanres.0386.2018. doi: 10.1158/1541-7786.MCR-18-0386.
  • > 44- Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.

    Tensaouti F, Khalifa J, Lusque A, Plas B, Lotterie JA, Berry I, Laprie A, Cohen-Jonathan Moyal E, Lubrano V.

    Neuroradiology. 2017 Oct;59(10):1013-1020. doi: 10.1007/s00234-017-1899-7.
  • > 21- Subventricular zones: new key targets for glioblastoma treatment.

    Khalifa J, Tensaouti F, Lusque A, Plas B, Lotterie JA, Benouaich-Amiel A, Uro-Coste E, Lubrano V, Cohen-Jonathan Moyal E.

    Radiat Oncol. 2017 Apr 20;12(1):67. doi: 10.1186/s13014-017-0791-2.
  • > 11- fMRI study of graduated emotional charge for detection of covert activity using passive listening to narratives.

    Sontheimer A, Vassal F, Jean B, Feschet F, Lubrano V, Lemaire JJ.

    Neuroscience. 2017 Feb 25. pii: S0306-4522(17)30139-2. doi: 10.1016/j.neuroscience.2017.02.048.
  • > Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.

    Ken S, Deviers A, Filleron T, Catalaa I, Lotterie JA, Khalifa J, Lubrano V, Berry I, Péran P, Celsis P, Moyal EC, Laprie A.

    J Neurooncol. 2015 Sep;124(3):465-73. doi: 10.1007/s11060-015-1860-8.
  • > Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.

    Dahan P, Martinez Gala J, Delmas C, Monferran S, Malric L, Zentkowski D, Lubrano V, Toulas C, Cohen-Jonathan Moyal E, Lemarie A.

    Cell Death Dis. 2014 Nov 27;5:e1543. doi: 10.1038/cddis.2014.509.
  • > Anatomical correlates for category-specific naming of objects and actions: a brain stimulation mapping study.

    Lubrano V, Filleron T, Démonet JF, Roux FE.

    Hum Brain Mapp. 2014 Feb;35(2):429-43. doi: 10.1002/hbm.22189.